Memory Cells in Atopic Dermatitis: Paving the Way to Disease Modification
International Journal of Molecular Sciences · 2026
DOI: 10.3390/ijms27052371 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Raquel Dominguez-Lopez und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Hospital Universitario Ramon y Cajal, Instituto Ramón y Cajal de Investigación Sanitarian (IRYCIS), 28034 Madrid, Spain. Hauptthemen laut MEDLINE: Immunologic Memory, Dermatitis, Atopic. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 110 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Atopic dermatitis (AD) is a chronic relapsing inflammatory skin disease in which persistence of immunological memory underlies disease recurrence and progression toward atopic comorbidities. Evidence indicates that pathogenic tissue-resident memory T cells (TRM), including Th2- and Th22-skewed subsets, among others, persist in both lesional and clinically resolved skin and rapidly re-initiate inflammation through production of IL-4, IL-13, IL-22 and IL-31, promoting barrier dysfunction and pruritus. In parallel, circulating CLA+ memory T cells retain skin-homing capacity and contribute to flare reactivation, while IgG1+CD23 IL-4Rα+ type-2 memory B cells (MBC2) constitute a reservoir for high-affinity IgE production, linking cutaneous inflammation with allergic comorbidities. These adaptive memory compartments are sustained by epithelial alarmins, dendritic cell–derived chemokines such as CCL17, CCL22 and CCL18, and the OX40/OX40L costimulatory pathway, which promotes differentiation, survival and tissue retention of memory T cells. Clinical and transcriptomic studies show how, although IL-4/IL-13 blockade reduces circulating type-2 responses, Th2A cells, Tc2 cells and activated dendritic cells can persist in clinically resolved skin, providing a mechanistic basis for relapse after treatment withdrawal. Together, these findings support the relevance of targeting memory-imprinting pathways as a promising mechanism to achieve durable disease modification in AD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Dermatology, Hospital Universitario Ramon y Cajal, Instituto Ramón y Cajal de Investigación Sanitarian (IRYCIS), 28034 Madrid, Spain.
- Department of Biochemistry and Molecular Biology II, School of Pharmacy, University of Granada, 18071 Granada, Spain.
- Institute of Nutrition and Food Technology "José Mataix" (INYTA), Centre of Biomedical Research, University of Granada, 18016 Granada, Spain.
- Faculty of Medicine, Universidad Francisco de Vitoria, 28223 Madrid, Spain.
ORCID-Profile: Raquel Dominguez-Lopez, Carlos J Aranda, Javier Perez-Bootello, Carlota Abbad-Jaime de Aragon, Emilio Berna-Rico
Zitieren
APA
Dominguez-Lopez, R., Aranda, C. J., Gómez-de la Fuente, E., Pérez-García, B., Perez-Bootello, J., Abbad-Jaime de Aragon, C., González-Cantero, Á., & Berna-Rico, E. (2026). Memory Cells in Atopic Dermatitis: Paving the Way to Disease Modification. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27052371
Vancouver
Dominguez-Lopez R, Aranda CJ, Gómez-de la Fuente E, Pérez-García B, Perez-Bootello J, Abbad-Jaime de Aragon C, et al. Memory Cells in Atopic Dermatitis: Paving the Way to Disease Modification. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27052371
BibTeX
@article{DominguezLopez2026,
author = {Dominguez-Lopez, Raquel and Aranda, Carlos J and Gómez-de la Fuente, Enrique and Pérez-García, Bibiana and Perez-Bootello, Javier and Abbad-Jaime de Aragon, Carlota and González-Cantero, Álvaro and Berna-Rico, Emilio},
title = {Memory Cells in Atopic Dermatitis: Paving the Way to Disease Modification},
journal = {International Journal of Molecular Sciences},
year = {2026},
doi = {10.3390/ijms27052371}
}
EUVIMED